People with type 2 diabetes who underwent Roux-en-Y gastric bypass were more likely to have diabetes remission at 5 years than those who received sleeve gastrectomy.
The overall cancer risk was higher in individuals with T2D at a younger age, and the risk decreased as age increased at diagnosis, a prospective study in China found.